CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical development of the BBV87 vaccine candidate.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3klKv4K
via IFTTT
0 comments:
Post a Comment